Tenet Healthcare Corporation (NYSE:THC – Get Free Report) EVP Lisa Foo sold 24,000 shares of the firm’s stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $266.32, for a total transaction of $6,391,680.00. Following the completion of the transaction, the executive vice president directly owned 8,053 shares of the company’s stock, valued at approximately $2,144,674.96. This trade represents a 74.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.
Tenet Healthcare Trading Down 0.2%
NYSE:THC opened at $265.35 on Wednesday. The company has a market cap of $21.37 billion, a P/E ratio of 10.23, a P/E/G ratio of 1.02 and a beta of 1.23. Tenet Healthcare Corporation has a 1 year low of $157.58 and a 1 year high of $283.05. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. The stock’s fifty day moving average price is $233.42 and its two-hundred day moving average price is $210.44.
Tenet Healthcare (NYSE:THC – Get Free Report) last announced its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. The firm had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the prior year, the firm posted $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, analysts expect that Tenet Healthcare Corporation will post 20.98 EPS for the current year.
Institutional Investors Weigh In On Tenet Healthcare
Analyst Upgrades and Downgrades
A number of research analysts recently commented on the company. UBS Group increased their target price on Tenet Healthcare from $288.00 to $308.00 and gave the company a “buy” rating in a research note on Monday, July 27th. Barclays lifted their price target on shares of Tenet Healthcare from $240.00 to $271.00 and gave the stock an “overweight” rating in a research note on Friday, July 24th. Piper Sandler set a $308.00 price objective on shares of Tenet Healthcare in a research note on Monday, July 27th. TD Cowen boosted their price target on shares of Tenet Healthcare from $233.00 to $263.00 and gave the stock a “buy” rating in a research note on Monday, July 27th. Finally, Morgan Stanley raised their price objective on Tenet Healthcare from $254.00 to $274.00 and gave the company an “overweight” rating in a research note on Monday, July 27th. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $273.00.
Get Our Latest Research Report on Tenet Healthcare
About Tenet Healthcare
Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
Read More
- Five stocks we like better than Tenet Healthcare
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
